Skip to content
10-Q

Quarterly Report

ADAPTIN BIO, INC. APTN

0001213900-24-098361

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 14, 2024 5M sh
Current Liabilities Q3 2024 · Sep 30, 2024 $235.64K
Current Liabilities Q3 2024 · Dec 31, 2023 $113.28K
Total Liabilities Q3 2024 · Sep 30, 2024 $235.64K
Total Liabilities Q3 2024 · Dec 31, 2023 $113.28K
Current Assets Q3 2024 · Sep 30, 2024 $322
Current Assets Q3 2024 · Dec 31, 2023 $380
Total Assets Q3 2024 · Sep 30, 2024 $322
Total Assets Q3 2024 · Dec 31, 2023 $380
Shares Diluted Q3 2024 · Sep 30, 2023 5M sh
Shares Diluted Q3 2024 · Sep 30, 2023 5M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$22.69K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$78.74K
Stockholders Equity Q3 2024 · Jun 30, 2023 −$35.8K
Stockholders Equity Q3 2024 · Mar 31, 2023 −$31.55K
Stockholders Equity Q3 2024 · Dec 31, 2022 −$27.3K
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Sga Expense Q3 2024 · Sep 30, 2023 $42.94K
Sga Expense Q3 2024 · Sep 30, 2023 $51.44K
Net Income Q3 2024 · Sep 30, 2023 −$42.94K
Net Income Q3 2024 · Sep 30, 2023 −$51.44K
Net Income Q3 2024 · Jun 30, 2023 −$4.25K
Net Income Q3 2024 · Mar 31, 2023 −$4.25K